1.Ferguson, CJ, Coulson, M, Barnett, J. A meta-analysis of pathological gaming prevalence and comorbidity with mental health, academic and social problems. J Psychiatr Res. 2011; 45(12): 1573–1578.
2.Nowak, DE. A meta-analytical synthesis and examination of pathological and problem gambling rates and associated moderators among college students, 1987–2016. J Gambl Stud. 2018; 34(2): 465–498.
3.Grant, JE, Schreiber, L, Odlaug, BL, et al. Pathologic gambling and bankruptcy. Compr Psychiatry. 2010; 51(2): 115–120.
4.Grant, JE, Chamberlain, SR. Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence? Addict Behav. 2014; 39(11): 1632–1639.
5.Marazziti, D, Picchetti, M, Baroni, S, et al. Pathological gambling and impulsivity: an Italian study. Riv Psichiatr. 2014; 49(2): 95–99.
6.Chowdhury, NS, Livesey, EJ, Blaszczynski, A, Harris, JA. Pathological gambling and motor impulsivity: a systematic review with meta-analysis. J Gambl Stud. 2017; 33(4): 1213–1239.
7.Ioannidis, K, Hook, R, Wickham, K, Grant, JE, Chamberlain, SR. Impulsivity in gambling disorder and problem gambling: a meta-analysis. Neuropsychopharmacology. 2019. doi: 10.1038/s41386-019-0393-9. [Epub ahead of print]
8.Yücel, M, Oldenhof, E, Ahmed, SH, et al. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study. Addiction. 2019; 114(6): 1095–1109.
9.Goudriaan, AE, Yucel, M, Van Holst, RJ. Getting a grip on problem gambling: what can neuroscience tell us? Front Behav Neurosci. 2014; 8: 141.
10.Oakes, J, Pols, R, Battersby, M, et al. A focus group study of predictors of relapse in electronic gaming machine problem gambling, part 1: factors that ‘push’ towards relapse. J Gambl Stud. 2012; 28(3): 451–464.
11.Blaszczynski, A, Nower, L. A pathways model of problem and pathological gambling. Addiction. 2002; 97(5): 487–499.
12.Nower, L, Martins, SS, Lin, KH, et al. Subtypes of disordered gamblers: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction. 2013; 108(4): 789–798.
13.Sharpe, L. A reformulated cognitive-behavioral model of problem gambling. A biopsychosocial perspective. Clin Psychol Rev. 2002; 22(1): 1–25.
14.Sharpe, L, Tarrier, N. Towards a cognitive-behavioural theory of problem gambling. Br J Psychiatry. 1993; 162: 407–412.
15.Valleur, M, Codina, I, Venisse, JL, et al. Towards a validation of the three pathways model of pathological gambling. J Gambl Stud. 2016; 32(2):757–771.
16.Tassorelli, C, Micieli, G, Osipova, V, et al. Pupillary and cardiovascular responses to the cold-pressor test. J Auton Nerv Syst. 1995; 55(1–2): 45–49.
17.Velasco, M, Gomez, J, Blanco, M, et al. The cold pressor test: pharmacological and therapeutic aspects. Am J Ther. 1997; 4(1): 34–38.
18.Kreek, MJ. Cocaine, dopamine and the endogenous opioid system. J Addict Dis. 1996; 15(4): 73–96.
19.Kreek, MJ. Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res. 1996; 21(11): 1469–1488.
20.Grant, JE, Kim, SW. Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry. 2001; 62(12): 957–962.
21.Barry, DT, Pilver, C, Potenza, MN, et al. Prevalence and psychiatric correlates of pain interference among men and women in the general population. J Psychiatr Res. 2012; 46(1): 118–127.
22.Barry, DT, Pilver, CE, Hoff, RA, et al. Pain interference and incident mood, anxiety, and substance-use disorders: findings from a representative sample of men and women in the general population. J Psychiatr Res. 2013; 47(11): 1658–1664.
23.Barry, DT, Pilver, CE, Hoff, RA, et al. Pain interference, gambling problem severity, and psychiatric disorders among a nationally representative sample of adults. J Behav Addict. 2013; 2(3): 138–144.
24.Ekholm, O, Davidsen, M, Larsen, CVL, et al. A nationwide study of health-related quality of life, stress, pain or discomfort and the use of medicine among problem gamblers. Scand J Public Health. 2018; 46(5): 514–521.
25.Parke, A, Griffiths, M, Pattinson, J, et al. Age-related physical and psychological vulnerability as pathways to problem gambling in older adults. J Behav Addict. 2018; 7(1): 137–145.
26.Winchester, WJ, Gore, K, Glatt, S, et al. Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans. J Pharmacol Exp Ther. 2014; 351(2): 259–269.
27.Duerden, EG, Albanese, MC. Localization of pain-related brain activation: a meta-analysis of neuroimaging data. Hum Brain Mapp. 2013; 34(1): 109–149.
28.Zois, E, Kiefer, F, Lemenager, T, et al. Frontal cortex gray matter volume alterations in pathological gambling occur independently from substance use disorder. Addict Biol. 2017; 22(3): 864–872.
29.Sheehan, DV, Lecrubier, Y, Sheehan, KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59(Suppl.20): 22–33.
30.Chamberlain, SR, Grant, JE. Minnesota Impulse Disorders Interview (MIDI): validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample. Psychiatry Res. 2018; 265: 279–283.
31.Grant, JE. Impulse Control Disorders: A Clinician’s Guide to Understanding and Treating Behavioral Addictions. New York: WW Norton and Company; 2008.
32.Grant, JE, Steinberg, MA, Kim, SW, et al. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res. 2004; 128(1): 79–88.
33.Pallanti, S, Decaria, CM, Grant, JE, et al. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud. 2005; 21(4): 431–443.
34.Kim, SW, Grant, JE, Potenza, MN, et al. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009; 166(1): 76–84.
35.Patton, JH, Stanford, MS, Barratt, ES. Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 1995; 51(6): 768–174.
36.Edens, L, Gil, KM. Experimental induction of pain: utility in the study of clinical pain. Behavior Therapy. 1995; 26: 197–216.
37.Al’Absi, M, Wittmers, LE, Ellestad, D, et al. Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004; 66(2): 198–206.
38.Wong, DL, Baker, CM. Smiling faces as anchor for pain intensity scales. Pain. 2001; 89(2–3): 295–300.
39.Rich, JT, Neely, JG, Paniello, RC, Voelker, CC, Nussenbaum, B, Wang, EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010; 143(3): 331–336.
40.Grant, JE, Kim, SW, Hartman, BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008; 69(5): 783–789.
41.Van den Brink, W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev. 2012; 5(1): 3–31.
42.Yip, SW, Potenza, MN. Treatment of gambling disorders. Curr Treat Options Psychiatry. 2014; 1(2): 189–203.
43.Kim, SW, Grant, JE. The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 2001; 6(3): 184–194.